Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology
NEW YORK, May 29 /PRNewswire/ -- ExL Pharma (http://www.exlpharma.com) is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical, Biotech and Medical Technology Corporate and Brand Communicators taking place on July 14-15, 2008 at the Heldrich Conference Center in New Brunswick, N.J. (http://www.exlpharma.com/eventDetail.php?id=112) Susan Winckler, Chief of Staff at the FDA will share an update on improving communication issues with the FDA. This presentation is much anticipated as a result of ongoing press on the relationship between the agency and industry. Also confirmed to speak is Peter Thonis, Chief Communications Officer with Verizon. Mr. Thonis is going to lend his insight to the pharmaceutical executives in attendance on communicating with key stakeholders and keeping customers, an area that Verizon has had much success.
The 4th Annual Public Relations and Communications Summit (http://www.exlpharma.com/eventDetail.php?id=112) event brings together communication executives, press and agencies to discuss best practices and challenges relating to corporate, brand and internal communication strategies. Now in its 4th year, this premier event has grown to become the industry standard for senior executives seeking educational and networking opportunities in this field.
Additional program highlights include the number of industry case studies around key issues and challenges that our industry is currently facing. Topics that will be discussed include: new media tools, communicating more effectively with press, internal communications, handling a crisis, the ongoing reputation challenge, DTC advertising, key policy and legislative issues, ROI measurement, corporate social responsibility, agency/client relations, advocacy relations, marketing & PR collaboration, global PR, and much more.
Speakers include senior representatives from many of the leading pharmaceutical, biotech and medical technology companies such as: Abbott, BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer, sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.
This premier event is co-sponsored by DS Simon, Fleishman Hillard, Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.
By attending this event, you will have the rare opportunity to networking with highly regarded communication executives from this industry, leading agency executives and key press/media such as the Wall Street Journal.
To maximize your company's exposure and take advantage of senior-level networking opportunities through sponsorship and exhibiting, please contact: Bryon Main, at email@example.com or by phone at 212-400-6246
To view the full program agenda and full roster of our expert speaking
faculty and to REGISTER*
Log onto: http://www.exlpharma.com
* When registering, provide Registration and Priority Code: P218PR1
EARLY REGISTRATION RATES EXPIRE TOMORROW -MAY 30TH- REGISTER NOW AND SAVE
ExL Pharma, a division of ExL Events, Inc., is an international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.
|SOURCE ExL Pharma|
Copyright©2008 PR Newswire.
All rights reserved